Press Release
Collaborating with Mekonos to advance non-viral cell engineering
This collaboration will combine the Mekonos novel ex vivo delivery platform with bit.bio’s opti-ox precision cellular reprogramming technology.
04.05.2023This collaboration will combine the Mekonos novel ex vivo delivery platform with bit.bio’s opti-ox precision cellular reprogramming technology.